GHP Investment Advisors Inc. Has $9.95 Million Stock Holdings in McKesson Co. (NYSE:MCK)

GHP Investment Advisors Inc. lifted its stake in McKesson Co. (NYSE:MCK) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 17,457 shares of the company’s stock after acquiring an additional 150 shares during the quarter. GHP Investment Advisors Inc.’s holdings in McKesson were worth $9,949,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Synergy Asset Management LLC bought a new position in shares of McKesson in the fourth quarter valued at $32,000. MidAtlantic Capital Management Inc. acquired a new position in shares of McKesson during the 3rd quarter worth about $29,000. Crews Bank & Trust bought a new stake in shares of McKesson in the 4th quarter valued at about $33,000. Wolff Wiese Magana LLC lifted its stake in McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after purchasing an additional 52 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new position in McKesson during the third quarter worth approximately $31,000. Institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on MCK. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Bank of America lowered their target price on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Robert W. Baird upgraded McKesson from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $531.00 to $688.00 in a research note on Thursday, November 7th. Wells Fargo & Company lifted their target price on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a report on Friday, December 13th. Finally, Mizuho started coverage on shares of McKesson in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 price target on the stock. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and a consensus price target of $646.14.

McKesson Stock Performance

McKesson stock opened at $605.37 on Thursday. The stock has a fifty day moving average of $589.61 and a 200-day moving average of $562.56. The stock has a market capitalization of $76.85 billion, a P/E ratio of 31.35, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $637.51.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. On average, research analysts forecast that McKesson Co. will post 32.72 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Monday, March 3rd. McKesson’s payout ratio is 14.71%.

Insider Activity at McKesson

In related news, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the sale, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. This trade represents a 40.12 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.11% of the stock is currently owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.